M
Milada Cvancarova
Researcher at University of Oslo
Publications - 113
Citations - 5445
Milada Cvancarova is an academic researcher from University of Oslo. The author has contributed to research in topics: Population & Inflammatory bowel disease. The author has an hindex of 42, co-authored 111 publications receiving 4614 citations. Previous affiliations of Milada Cvancarova include University of Bergen & University College of Applied Sciences.
Papers
More filters
Journal ArticleDOI
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
Inger Camilla Solberg,Idar Lygren,Jørgen Jahnsen,Erling Aadland,Ole Høie,Milada Cvancarova,Tomm Bernklev,Magne Henriksen,Jostein Sauar,Morten H. Vatn,Bjørn Moum +10 more
TL;DR: The prognosis for UC during the first 10 years was generally good, the colectomy rate was low, and a large proportion of patients were in remission as time progressed, suggesting patients with initially extensive colitis and elevated ESR could benefit from an early potent medical treatment strategy.
Journal ArticleDOI
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma
Arne Westgaard,Svetlana Tafjord,Inger N Farstad,Milada Cvancarova,Tor J. Eide,Øystein Mathisen,Ole Petter F. Clausen,Ivar P. Gladhaug +7 more
TL;DR: Pancreatobiliary versus intestinal type of differentiation independently predicts poor prognosis after pancreaticoduodenectomy for periampullary adenocarcinoma, and lymph node status, vessel involvement, and tumour diameter remained independent prognostic factors.
Journal ArticleDOI
Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer Survivors
TL;DR: The presence of both alleles of 105Val-GSTP1 offered protection against cisplatin-induced hearing impairment, and two genotype patterns with good and poor protection against bisphosphorus-induced ototoxicity were identified.
Journal ArticleDOI
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
Marte Lie Høivik,Bjørn Moum,Inger Camilla Solberg,Magne Henriksen,Milada Cvancarova,Tomm Bernklev +5 more
TL;DR: Ten years after disease onset IBD patients had an increased RR for disability pension (DP) as compared with the background population, and the youngest patients had the highest RR.
Journal ArticleDOI
Predictors and course of chronic fatigue in long-term breast cancer survivors
Kristin V. Reinertsen,Milada Cvancarova,Jon Håvard Loge,Jon Håvard Loge,Hege Edvardsen,Hege Edvardsen,Erik Wist,Erik Wist,Sophie D. Fosså,Sophie D. Fosså +9 more
TL;DR: During follow-up, BCSs and their doctors should maximize their efforts to reduce psychological distress, overweight and pain within the BC-treated area, all linked to the development of persistent fatigue.